The winners of this grant will have the opportunity to analyze up to 96 areas of illumination (AOIs) in human tissues distributed in 4 slides (maximum).

The awarded profiling reagents included are the Immune Cell Profiling Core panel, which contains 18 key biomarkers in immuno-oncology and immune cell markers (T cells, B cells, macrophages, NK cells, epithelium and stroma) as well as the controls required for the GeoMx DSP assays. In addition, we offer the possibility to increase the number of biomarkers studied including two additional modules with no extra costs:

1.- Immune Activation Status Module: includes additional checkpoint molecules that modulate T-cell activation

2.- Immune Cell Typing Module: Includes an expanded set of cell markers to further delineate cell types (for example T-cell subtyping)

The grant includes all reagents required for processing and nCounter read out of 4 slides at Citogen’s lab (with up to 24 AOIs per slide, 96 AOI for the entire project). It also includes the standard morphology markers kit with these three specific fluorescence-labeled cell typing antibodies to reveal tissue structure (Pan-CK, CD45 and nuclear marker).

We invite all researchers attending the Nanostring’s Spatial Genomics Seminar on the June 23^rd 2022 at Instituto Gulbenkian Ciencia, Oeiras Portugal and their respective research groups to apply for this grant by sending an abstract of your project (in Portuguese or English).  The prize will be awarded to the proposal with highest impact.

Important Notice:

The deadline for submitting applications has been extended through
15th september

Terms & Conditions

Deadline for applications:

The deadline for applications has been extended through 23:59 WEST, September 15^th 2022. Please, fill in the application form which should include a short summary of their project and objectives (maximum 500 words). In case of doubts or difficulties in sending the application, please contact info@dlongwood.com.

Eligibility and Requirements:

Applicants must be actively enrolled or employed at an institution or company located in Portugal and working in a capacity in which they perform life science research. Recipients must be age 18 or older. In addition, they must be able to submit RNA samples for analysis within 60 days of notification of award.

Members of the immediate families of NanoString/Diagnostica Longwood & Citogen employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program.

Grant Award:

The grant recipient will be awarded with the service to process 4 slides with the human version of the Immune Cell Profiling Core Protein Panel plus 2 additional modules (Immune Activation Status Module & Immune Cell Typing Module) that allows a maximum of 4 slides and 96 area of illumination for the whole experiment as well as a set of solid tumor morphology markers kit including PanCK, CD45 and Syto13.

Projects will be run in core facilities of Citogen lab at Zaragoza, Spain. A basic data analysis service will be provided.

Publication of project results:

Upon completion of the project, the grant winner agrees to participate in at least one of the following activities related to the publicity of the specific project, the specific details of the applicable activity being agreed jointly and in good faith by Diagnóstica Longwood S.L., Citogen, NanoString and each winner: webinar, case study presentation, publication in blog and/or on the Diagnóstica Longwood S.L and/or Nanostring website, or poster presentation.

Each winner agrees that Diagnóstica Longwood S.L., Citogen and NanoString shall have the right to publicly announce the winner’s name and research topic and to use, on an anonymous basis, data from the winner’s project in various applications, including marketing materials and seminars/workshops.

Others:

All applicants agree that Diagnóstica Longwood S.L., Citogen and NanoString may process the personal data he or she provides as part of the application, including sharing such data with Diagnóstica Longwood S.L ’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with Diagnóstica Longwood S.L. privacy policies available at https://www.dlongwood.com/en/privacy-policy/

Award recipients may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by Diagnóstica Longwood S.L., Citogen and NanoString.

No substitution or transfer of the award is allowed, except if Diagnóstica Longwood S.L. and NanoString allow it after evaluation of a formal request where the reason for such a transfer must be indicated.

Award winners are responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award.

If, for any reason, this grant program may not run as planned for any causes beyond the reasonable control of Diagnóstica Longwood S.L., Citogen and NanoString. The three companies reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. Diagnóstica Longwood S.L., Citogen and NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law.

These terms and conditions and any action related to this grant program will be governed by the laws of Spain without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Zaragoza, Spain, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.